Pharmacologic characterization of a novel histamine receptor on human eosinophils

American Journal of Respiratory and Critical Care Medicine

Volumn 149, Issue 6, 1994, Pages 1506-1511

  Raible, Donald C ^a   Lenahan, Terrence ^a   Fayvilevich, Yelena ^a   Kosinski, Robert ^a   Schulman, Edward S ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA METHYLHISTAMINE; BURIMAMIDE; CALCIUM; CELL RECEPTOR; CIMETIDINE; DIGITONIN; DIMAPRIT; FURA 2; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; IMPROMIDINE; MEPYRAMINE; N METHYLHISTAMINE; TESMILIFENE; THIOPERAMIDE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG POTENCY; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0028308210     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.149.6.8004306     Document Type: Article

References (28)

1. Lett AR, Hamann KJ, Wegner CD. Inflammation and cell-cell interactions in airway hyperresponsiveness. Am J Physiol 1991;260:L189-L206.
2. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253.
3. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;324: 1110-8.
4. Sedgwick JB, Busse WB. Histamine regulation of granulocyte function. In: Rocklin RS, ed. Histamine and H2 antagonists in inflammation and immunodeficiency. New York: Marcel Dekker, 1990;107-36.
5. 2 and histamine activate human eosinophils. J Immunol 1992;148:3536-42.
6. Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983;302:832-7.
7. Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC. Highly potent and selective ligands for histamine H3-receptors. Nature 1987;327:117-23.
8. Randolph TG. Blood studies in allergy. I. The direct counting chamber determination of eosinophils by propylene glycol aqueous stains. J Allergy 1944;15:89.
9. Gärtner I. Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica (Percoll). Immunol 1980;40:133-6.
10. Yazdanbakhsh M, Eckmann CM, Koenderman L, Verhoeven AJ, Roos D. Eosinophils do respond to fMLP. Blood 1987;70:379-83.
11. Schild HO. pAx and competitive drug antagonism. Br J Pharm 1949; 4:277-80.
12. Rotrosen D, Gallin JH. Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers. J Cell Biol 1986; 103:2379-87.
13. Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990;42:45-83.
14. Schlicker E, Behling A, Lummen G, Gothert M. Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn Schmiedebergs Arch Pharmacol 1992;345:489-93.
15. Waud DR. On the measurement of the affinity of partial agonists for receptors. J Pharm Exp Ther 1969;170:117-22.
16. Saxena SP, Brandes LJ, Becker AB, Simons KJ, LaBella FS, Gerrard JM. Histamine is an intracellular messenger mediating platelet aggregation. Science 1989;243:1596-9.
17. Brandes LJ, LaBella FS, Glavin GB, Paraskevas F, Saxena SP, McNicol A, Gerrard JM. Histamine as an intracellular messenger. Biochem Pharmacol 1990;40:1677-81.
18. Clark RA, Gallin JI, Kaplan AP. The selective eosinophil chemotactic activity of histamine. J Exp Med 1975;142:1462-76.
19. Clark RAF, Sandler JA, Gallin JI, Kaplan AP. Histamine modulation of eosinophil migration. J Immunol 1977;118:137-45.
20. Clark RA, Gallin JI, Kaplan AP. The nature of histamine control of eosinophil localization. In: Gallin JI, Quie PG, eds. Leukocyte chemotaxis. New York: Raven Press, 1978;195-210.
21. Wadee AA, Anderson R, Sher R. In vitro effects of histamine on eosinophil migration. Int Arch Allergy Appl Immunol 1980;63:322-9.
22. Busse WW, Sosman J. Decreased H2 histamine response of granulocytes of asthmatic patients. J Clin Invest 1977;59:1080-7.
23. Pincus SH, DiNapoli AM, Schooley WR. Superoxide production by eosinophils: activation by histamine. J Invest Derm 1982;79:53-7.
24. Anwar AR, Kay AB. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature 1977; 269:522-4.
25. Anwar AR, Kay B. Enhancement of human eosinophil complement receptors by pharmacologic mediators. J Immunol 1978;121:1245-50.
26. Anwar AR, Kay AB. H1-receptor dependence of histamine-induced enhancement of human eosinophil C3b rosettes. Clin Exp Immunol 1980;42:196-9.
27. West R Jr, Zweig A, Shih NY, Siegel Ml, Egan RW, Clark MA. Identification of two H3-histamine receptor subtypes. Mol Pharm 1990;38:610-3.
28. Clapham J, Kilpatrick GJ. Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes. Br J Pharmacol 1992;107:919-23.